美好医疗
(301363)
| 流通市值：86.40亿 | | | 总市值：131.73亿 |
| 流通股本：5.22亿 | | | 总股本：7.96亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 813,213,029.1 | 403,077,520.81 | 1,625,486,540.42 | 1,194,474,058.15 |
| 营业总成本 | 658,047,574.57 | 337,442,473.35 | 1,273,131,275.66 | 948,450,698.88 |
| 其他经营收益 | | | | |
| 营业利润 | 144,836,705.57 | 65,280,178.23 | 325,197,321.53 | 237,755,302.27 |
| 利润总额 | 144,912,824.41 | 65,301,710.11 | 324,696,407.61 | 237,798,946.55 |
| 净利润 | 124,324,075.36 | 56,683,601.11 | 283,080,971.9 | 208,202,331.16 |
| 每股收益 | | | | |
| 其他综合收益 | -36,881,916.3 | -11,024,063.8 | 42,384,985.1 | 21,867,006.73 |
| 综合收益总额 | 87,442,159.06 | 45,659,537.31 | 325,465,957 | 230,069,337.89 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,442,077,937.07 | 2,461,298,469.76 | 2,455,066,464.22 | 2,441,744,660.55 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,764,844,391.39 | 1,790,855,172.46 | 1,778,806,955.08 | 1,737,752,688.63 |
| 资产总计 | 4,206,922,328.46 | 4,252,153,642.22 | 4,233,873,419.3 | 4,179,497,349.18 |
| 流动负债: | | | | |
| 流动负债合计 | 435,888,340.72 | 392,712,646.31 | 429,591,776.45 | 403,851,160.92 |
| 非流动负债: | | | | |
| 非流动负债合计 | 78,578,911.4 | 74,907,304.95 | 70,842,222.39 | 73,676,412.67 |
| 负债合计 | 514,467,252.12 | 467,619,951.26 | 500,433,998.84 | 477,527,573.59 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,692,455,076.34 | 3,784,533,690.96 | 3,733,439,420.46 | 3,701,969,775.59 |
| 股东权益合计 | 3,692,455,076.34 | 3,784,533,690.96 | 3,733,439,420.46 | 3,701,969,775.59 |
| 负债和股东权益合计 | 4,206,922,328.46 | 4,252,153,642.22 | 4,233,873,419.3 | 4,179,497,349.18 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 871,821,577.17 | 441,594,099.82 | 1,777,851,140.16 | 1,295,860,795.12 |
| 经营活动现金流出小计 | 706,125,648.32 | 370,798,638.12 | 1,425,699,954.65 | 1,073,887,376.47 |
| 经营活动产生的现金流量净额 | 165,695,928.85 | 70,795,461.7 | 352,151,185.51 | 221,973,418.65 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 984,262,595.4 | 514,798,795.13 | 3,156,754,218.48 | 2,138,823,892.5 |
| 投资活动现金流出小计 | 722,490,859.35 | 349,241,577.16 | 3,242,276,314.24 | 2,379,055,942 |
| 投资活动产生的现金流量净额 | 261,771,736.05 | 165,557,217.97 | -85,522,095.76 | -240,232,049.5 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 29,837,100 | 29,837,100 | 162,163,069.92 | 86,179,310.6 |
| 筹资活动现金流出小计 | 142,262,752.86 | 33,084,959.08 | 143,749,231.08 | 76,026,115.66 |
| 筹资活动产生的现金流量净额 | -112,425,652.86 | -3,247,859.08 | 18,413,838.84 | 10,153,194.94 |
| 汇率变动对现金及现金等价物的影响 | -40,690,664.02 | -20,298,435.68 | -18,125,590.89 | 1,343,262.03 |
| 现金及现金等价物净增加额 | 274,351,348.02 | 212,806,384.91 | 266,917,337.7 | -6,762,173.88 |
| 期末现金及现金等价物余额 | 1,359,379,254.07 | 1,297,834,290.96 | 1,085,027,906.05 | 811,348,394.47 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 274,351,348.02 | - | 266,917,337.7 | - |
最新报告期：2026-08-20| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.45 | 0.58 | 0.71 | 2026-08-20 |
| 东北证券 | 叶菁,古翰羲 | 0.41 | 0.48 | 0.56 | 2026-08-20 |
| 东方证券 | 伍云飞 | 0.47 | 0.56 | 0.66 | 2026-08-20 |
| 西南证券 | 杜向阳 | 0.46 | 0.55 | 0.66 | 2026-08-18 |
| 华泰证券 | 代雯,孔垂岩,王殷杰 | 0.43 | 0.56 | 0.72 | 2026-08-18 |